In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] ? Forecast To 2017: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] ? Forecast To 2017 Jul 29th 2013, 00:00 The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

China poultry vaccine market analysis: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

China poultry vaccine market analysis Jul 29th 2013, 00:00 China poultry vaccine market analysis is an invaluable asset for anyone who wants to invest in the poultry vaccine industry, to import into/from China, to build factories in China, to partner with one of the key Chinese corporations, or to compete in the segment. The report provides in-depth analysis and detailed insight into the poultry vaccine industry, market drivers, key enterprises and their strategies, related policies, laws and standards for the industry, price trends, import and export data, projects to be constructed in China, forecasts, as well as technologies and investment status, risks and trends.The poultry vaccine indicates the products reproduced and processed from th...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Huntington's Disease Global Clinical Trials Review, H2, 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Huntington's Disease Global Clinical Trials Review, H2, 2013 Jul 22nd 2013, 00:00 Huntington''s Disease Global Clinical Trials Review, H2, 2013 GlobalData''s clinical trial report, ?Huntington''s Disease Global Clinical Trials Review, H2, 2013" provides data on the Huntington?s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Huntington?s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs fo...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022 Jun 30th 2013, 00:00 PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022 GlobalData has released its new Country report, ?PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022?. The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose market exclusivity during the next few years. GlobalData predicts that the major global barriers that will play a crucial role in narrowing the global growth of the CHF market over the forecast period include the sparsely populated CHF pipeline and an increasing number of generic competitors in a market th...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Sarcoidosis Global Clinical Trials Review, H2, 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Sarcoidosis Global Clinical Trials Review, H2, 2013 Jul 22nd 2013, 00:00 Sarcoidosis Global Clinical Trials Review, H2, 2013 GlobalData''s clinical trial report, ?Sarcoidosis Global Clinical Trials Review, H2, 2013" provides data on the Sarcoidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sarcoidosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sarcoidosis. This report is...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Hemostasis Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Japan, Spain, UK, US: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Hemostasis Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Japan, Spain, UK, US Jul 7th 2013, 00:00 Global Hemostasis Diagnostics Market: US, Europe, Japan, including supplier shares, and forecasts for 40 hemostasis procedures. This DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global hemostasis testing market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Geographic CoverageFranceGermanyItalyJapanSpainUKUSASales and Market Share AnalysisSales and market shares of major hemostasis testing instrument ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK Jul 7th 2013, 00:00 This DataPack contains 120 tables from Venture Planning Group new 5-country study, Hemostasis Testing in Europe Market Segment Forecasts and Supplier Shares,? including supplier shares, and forecasts for 40 hemostais procedures.  This DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European hemostasis testing market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Geographic CoverageFranceGermanyItalySpainUKSales and Market Share Analysis<...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests Jul 7th 2013, 00:00 This DataPack contains 103 tables from Venture Planning Group’s new report, US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.Market Segmentation Analysis- Sales and market shares of major suppliers, by individual tumor marker....

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Tumor Markers: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests France, Germany, Italy, Japan, Spain, UK, US: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Tumor Markers: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests France, Germany, Italy, Japan, Spain, UK, US Jul 7th 2013, 00:00 This DataPack contains 450 tables from Venture Planning Group’s new 7-country study, Tumor Markers: US, Europe, Japan,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.Geographic Coverage- France- Germany- Italy- Japan- Spain- UK- USAMarket Segmentation Analysis

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Tumor Markers: Granular Analysis of European Markets Supplier Shares and Forecasts for 40 Cancer Diagnostics Tests France, Germany, Italy, Spain, UK: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Tumor Markers: Granular Analysis of European Markets Supplier Shares and Forecasts for 40 Cancer Diagnostics Tests France, Germany, Italy, Spain, UK Jul 7th 2013, 00:00 This DataPack contains 320 tables from Venture Planning Group’s new 5-country study, Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.Geographic Coverage- France- Germany- Italy- Spain- UKMarket Segmentation Anal...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Point-of-Care Testing: Granular Analysis of the US Market Supplier Shares and Sales Forecasts for over 300 Tests: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Point-of-Care Testing: Granular Analysis of the US Market Supplier Shares and Sales Forecasts for over 300 Tests Jul 7th 2013, 00:00 This new report, Competing in the US Point-of-Care Diagnostic Testing Market,” including supplier shares, as well as test volume and sales by tests. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US Point-of-Care Testing market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Market Segmentation AnalysisReview of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline Jul 10th 2013, 00:00 GBI Research’s report Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline provides insights and analysis into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is no...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth Jun 30th 2013, 00:00 GBI Research, a leading business intelligence provider, has released its latest research report Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth”. The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach a value of $15.6 billion by 2019. Much of this growth will be fuelled by a high number of new, more efficacious and convenient products entering the market and commanding greater value compared to the therapies already in the market. The drugs driving this growth include once-daily LABA/LAMA fixed-dose combinations such as QVA-149, ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Left Ventricular Dysfunction - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Left Ventricular Dysfunction - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Left Ventricular Dysfunction - Pipeline Review, H1 2013 Global Markets Direct?s, ''Left Ventricular Dysfunction - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Dysfunction. Left Ventricular Dysfunction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s proprietary databases, Company/University websit...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Trauma - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Trauma - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Trauma - Pipeline Review, H1 2013 Global Markets Direct?s, ''Trauma - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Trauma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Trauma. Trauma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013 Global Markets Direct?s, ''Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL). Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s pro...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Blood Cancer - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Blood Cancer - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Blood Cancer - Pipeline Review, H1 2013 Global Markets Direct?s, ''Blood Cancer - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Blood Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Blood Cancer. Blood Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013 Global Markets Direct?s, ''Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Revi...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Hearing Disorders - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Hearing Disorders - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Hearing Disorders - Pipeline Review, H1 2013 Global Markets Direct?s, ''Hearing Disorders - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Hearing Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hearing Disorders. Hearing Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s proprietary databases, Company/University websites, SEC filings, investor presentations and featured pr...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Alpha - Antitrypsin Deficiency - Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Alpha - Antitrypsin Deficiency - Pipeline Review, H1 2013 Jun 30th 2013, 00:00 Alpha - Antitrypsin Deficiency - Pipeline Review, H1 2013 Global Markets Direct?s, ''Alpha - Antitrypsin Deficiency - Pipeline Review, H1 2013'', provides an overview of the indication?s therapeutic pipeline. This report provides information on the therapeutic development for Alpha - Antitrypsin Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alpha - Antitrypsin Deficiency. Alpha - Antitrypsin Deficiency - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct?s proprietary databases, Company/Univers...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

EpiCast Report: Pancreatic Cancer - Epidemiology Forecast to 2022: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

EpiCast Report: Pancreatic Cancer - Epidemiology Forecast to 2022 Jul 12th 2013, 00:00 Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries (Michaud, 2004). Pancreatic cancer originates from transformed cells from tissues within the exocrine component of the pancreas. The most common type is adenocarcinoma associated with the exocrine gland (ACS, 2013). The pancreas is found deep within the body, leading to the inability to detect pancreatic cancer early-on. Most cases of pancreatic cancer go undetected from the lack of obvious symptoms, causing the cancer to spread to other organs.The risk of developing pancreatic cancer is associated with increasing age, as more than 75% of pancreatic...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) ? Forecasts To 2017: Pharmaceuticals Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) ? Forecasts To 2017 Jul 9th 2013, 00:00 Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017. Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injec...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

North America Weight Loss/Obesity Management Market ? [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] ? Forecasts to 2017: Pharmaceuticals Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

North America Weight Loss/Obesity Management Market ? [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] ? Forecasts to 2017 Jul 8th 2013, 00:00 Obesity and weight gain have always been major concerns regarding the health and fitness of individuals; today, it has reached the level of an epidemic. Increasing obesity rate and increasing levels of awareness amongst calorie-conscious consumers in North America have opened new avenues for the weight management industry. The North American weight loss/obesity management market was worth $104 billion in 2012.The North America weight management market witnesses a growing preference for low-calorie diet food and beverages and slimmer waters/natural mineral salt drinks. With the introduction of technologically advanced and highly sophisticated fitness equipment, the use of cardiovascular and ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

PharmaFocus: Biomarkers in Alzheimer?s Disease: Pharmaceuticals Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

PharmaFocus: Biomarkers in Alzheimer?s Disease Jun 30th 2013, 00:00 PharmaFocus: Biomarkers in Alzheimer’s DiseaseAlzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The disease has emerged as a major global health priority especially because of its rapidly accelerating prevalence worldwide. In order to tackle the AD scourge , there is an urgent need for tools that will allow for the early and accurate diagnosis of AD, as well as the identification of populations at risk. A biomarker is an indicator of biological processes that can be objectively measured and evaluated, and well-validated biomarkers are re...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Muscular Dystrophy ? Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Muscular Dystrophy ? Pipeline Review, H1 2013 Jun 27th 2013, 00:00 Global Markets Direct’s, ''Muscular Dystrophy Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscular Dystrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Muscular Dystrophy. Muscular Dystrophy Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releas...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Insulin Resistance ? Pipeline Review, H1 2013: Pharmaceuticals Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Insulin Resistance ? Pipeline Review, H1 2013 Jun 27th 2013, 00:00 Global Markets Direct’s, ''Insulin Resistance - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Insulin Resistance, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Insulin Resistance. Insulin Resistance - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press re...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions